| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $276.4M | +61.2% |
| SG&A Expense | $168.4M | +2.0% |
| Operating Income | -$446.9M | -28.6% |
| Pre-tax Income | -$457.4M | -44.2% |
| Income Tax | $500K | — |
| Net Income | -$457.9M | -44.3% |
| EPS (Basic) | -$1.69 | -28.0% |
| EPS (Diluted) | -$1.69 | -28.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $464.6M | +569.5% |
| Current Assets | $480.2M | -12.0% |
| Total Assets | $554.3M | -3.4% |
| Current Liabilities | $114.0M | +113.9% |
| Long-term Debt | $7.2M | -22.6% |
| Total Liabilities | $187.2M | +132.5% |
| Stockholders' Equity | $367.1M | -25.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$271.6M | -35.5% |
| Capital Expenditures | $44.3M | +542.0% |
| Investing Cash Flow | $420.7M | +190.6% |
| Financing Cash Flow | $250.1M | +2626.3% |
| Free Cash Flow | -$315.9M | -52.4% |